Fredun Pharmaceuticals Limited (FREDUN.BO)
INR 762.1
(0.67%)
INR 762.1
(0.67%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -135.88 Million | -144.08 Million | -23.8 Million | 1.69 Million | -106.44 Million | 8.35 Million |
| Net Income | 156.23 Million | 107.57 Million | 63.12 Million | 20.12 Million | 23.45 Million | 61.78 Million |
| Depreciation & Amortization | 37.95 Million | 28.09 Million | 21.56 Million | 20.03 Million | 18.78 Million | 13.3 Million |
| Deferred income taxes | 2.93 Million | 24.11 Million | 541 Thousand | 4.36 Million | 1.48 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -381.57 Million | -435.67 Million | -187.72 Million | -104.95 Million | -189.91 Million | -69.57 Million |
| Other non-cash items | 640.05 Million | 88.9 Million | 56.58 Million | 54.57 Million | 44.47 Million | 2.84 Million |
| Investing Cash Flow | -76.39 Million | -94.04 Million | -41.43 Million | -13.87 Million | -14.92 Million | -52.51 Million |
| Investments in PPE | -76.39 Million | -94.94 Million | -42.86 Million | -13.87 Million | -14.92 Million | -164.01 Million |
| Acquisitions | - | 901 Thousand | 1.43 Million | - | - | 111.49 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 901 Thousand | 1.43 Million | - | - | 0.19 |
| Financing Cash Flow | 196.43 Million | 251.76 Million | 74.66 Million | -7.13 Million | 137.29 Million | 44.29 Million |
| Debt repayment | -189.63 Million | -340.66 Million | -131.25 Million | -47.44 Million | -181.76 Million | -138.01 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 5.64 Million |
| Other Financing Activities | 6.79 Million | 592.43 Million | 205.91 Million | 40.31 Million | 319.05 Million | 176.65 Million |
| Accounts receivables | -302.88 Million | 557.13 Million | -491.97 Million | -21.01 Million | -150.12 Million | -25.22 Million |
| Accounts payables | 36.04 Million | 107.26 Million | -113.43 Million | 137.37 Million | 104.84 Million | -52.16 Million |
| Inventory | -248.74 Million | -1.03 Billion | 211.14 Million | -171.12 Million | -96.81 Million | -223.54 Million |
| Other working capital | 134.01 Million | -63.43 Million | 206.54 Million | -50.18 Million | -47.81 Million | 231.36 Million |
| Cash at beginning of period | 32.78 Million | 20.71 Million | 11.28 Million | 30.59 Million | 14.66 Million | 14.53 Million |
| Cash at end of period | 11.09 Million | 34.35 Million | 20.71 Million | 11.28 Million | 30.59 Million | 14.66 Million |
| Capital Expenditure | -76.39 Million | -94.94 Million | -42.86 Million | -13.87 Million | -14.92 Million | -164.01 Million |
| Effect of forex changes on cash | - | -1000.00 | - | 1000.00 | - | - |
| Net cash flow / Change in cash | -21.68 Million | 13.63 Million | 9.43 Million | -19.3 Million | 15.92 Million | 134.38 Thousand |
| Free Cash Flow | -212.27 Million | -239.03 Million | -66.66 Million | -12.18 Million | -121.36 Million | -155.65 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 41.29 Million | 50.62 Million | 156.23 Million | 46.42 Million | 39.36 Million | 24.01 Million |
| Depreciation & Amortization | - | 9.44 Million | 37.95 Million | 9.44 Million | 9.38 Million | 9.15 Million |
| Deferred income taxes | - | - | 2.93 Million | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -195.02 Million | -381.57 Million | -195.02 Million | - | - |
| Other non-cash items | -41.29 Million | -57.54 Million | 640.05 Million | -53.35 Million | -39.36 Million | -24.01 Million |
| Investing Cash Flow | - | 5.24 Million | -76.39 Million | 5.24 Million | - | - |
| Investments in PPE | - | 5.24 Million | -76.39 Million | 5.24 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | 168.39 Million | 196.43 Million | 168.39 Million | - | - |
| Debt repayment | - | - | -189.63 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -2.31 Million | - | -1.15 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 170.7 Million | 6.79 Million | 169.54 Million | - | - |
| Accounts receivables | - | -445.3 Million | -302.88 Million | -445.3 Million | - | - |
| Accounts payables | - | - | 36.04 Million | - | - | - |
| Inventory | - | 472.43 Million | -248.74 Million | 472.43 Million | - | - |
| Other working capital | - | -222.14 Million | 134.01 Million | -222.14 Million | - | - |
| Cash at beginning of period | 13.5 Million | 32.37 Million | 32.78 Million | 19.18 Million | -20.17 Million | 32.78 Million |
| Cash at end of period | 13.5 Million | 13.5 Million | 11.09 Million | 38.9 Million | 19.18 Million | 24.01 Million |
| Capital Expenditure | - | 5.24 Million | -76.39 Million | 5.24 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -18.87 Million | -21.68 Million | 19.71 Million | 39.36 Million | -8.76 Million |
| Free Cash Flow | - | -187.26 Million | -212.27 Million | -187.26 Million | 39.36 Million | 24.01 Million |
ADRT
KPIFF
TRIMURTHI
GASX
FRVWY
TYCHE